Skip Navigation

JNCI Monographs 2003 2003(31):72-79;
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Sherman, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sherman, M. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute Monographs, No. 31, 72-79, 2003
© 2003 Oxford University Press

ARTICLE

Chapter 11: Future Directions in Cervical Pathology

Mark E. Sherman

Affiliation of author: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.

Correspondence to: Mark E. Sherman, M.D., National Institutes of Health, 6120 Executive Blvd., Rm. 7080, Bethesda, MD 20892-7374 (e-mail: shermanm{at}mail.nih.gov).

Technologic innovations, including the development of improved sampling devices, liquid-based collection systems, and computer-assisted screening, have revolutionized cervical cytology. Biologic discoveries in upcoming years promise to transform our understanding of the pathogenesis of cervical neoplasia, leading to another quantum leap in our approach to screening and prevention. This review summarizes the opportunities and challenges that recent and anticipated advances in pathology present for epidemiologic research.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JNCI J Natl Cancer InstHome page
J. D. Goldhaber-Fiebert, N. K. Stout, J. A. Salomon, K. M. Kuntz, and S. J. Goldie
Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination
J Natl Cancer Inst, March 5, 2008; 100(5): 308 - 320.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.